Alexandria New Medical Center Co.
EEGX:AMES33.41
EGP
-1.64
(-4.68%)
Alexandria New Medical Center Co.
EGX:AMES
(Egyptian Exchange)
Recent
price
33.41
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Alexandria New Medical Center Co. (Alexandria Medical Services – Alexandria New Medical Center S.A.E.) is an Egypt-based healthcare provider primarily engaged in the ownership, operation, and management of specialized and general hospital facilities. Founded in 1983 and headquartered in Alexandria, Egypt, the company delivers comprehensive inpatient, outpatient, diagnostic, and surgical medical services to private patients, corporate clients, and insured individuals across the Alexandria governorate and Northern Egypt. The company provides a broad portfolio of medical and surgical services, including general, laparoscopic, and bariatric surgery; cardiothoracic and vascular surgery; neurosurgery and spine surgery; orthopedics and traumatology; surgical and clinical oncology; urology and nephrology; obstetrics, gynecology, and reproductive medicine; pediatrics and neonatology; gastroenterology; ear, nose, and throat (ENT) surgery; ophthalmology; and dental care. Its specialized procedural and critical care infrastructure includes adult intensive care units (ICUs), coronary care units (CCUs), pediatric intensive care units (PICUs), and neonatal intensive care units (NICUs); a specialized kidney transplant and hemodialysis center; cardiac catheterization laboratories; and gastrointestinal endoscopy suites. The company also offers integrated diagnostic and auxiliary healthcare services, including clinical pathology, hematology, and microbiology laboratory testing; diagnostic radiology and medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT) scans, digital mammography, X-ray, and ultrasound; physical therapy and medical rehabilitation; and 24-hour emergency, trauma, and inpatient pharmaceutical services. In recent corporate developments, the company underwent a major ownership transformation and strategic restructuring following the acquisition of a controlling 96% equity stake by an investment consortium comprising Tawasol Holdings for Financial Investments and LimeVest Partners via a mandatory tender offer. Following the change in control, the company executed substantial capital increases approved by the Financial Regulatory Authority (FRA) through multi-million-share equity issuances to strengthen its financial position, fund operational expansions, modernize medical equipment, and upgrade clinical diagnostic and intensive care capabilities.